Paclitaxel succinate sulfo-NHS ester

Paclitaxel succinate sulfo-NHS ester is a derivative of Paclitaxel (HY-B0015) . Paclitaxel succinate sulfo-NHS ester can be used for the research of cancer[1].

Product Specifications

CAS Number

[192047-93-1]

Product Name Alternative

2’-Sulfo-NHS-succinyl-paclitaxel

UNSPSC

12352005

Target

Drug Derivative; Microtubule/Tubulin

Related Pathways

Cell Cycle/DNA Damage; Cytoskeleton; Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Smiles

CC(O[C@]12[C@@]3([H])[C@@H]([C@]4(C(C)(C([C@H](C([C@@]3([C@H](C[C@@]1([H])OC2)O)C)=O)OC(C)=O)=C([C@H](C4)OC([C@H](OC(CCC(ON5C(C(CC5=O)S(=O)(O)=O)=O)=O)=O)[C@H](C6=CC=CC=C6)NC(C7=CC=CC=C7)=O)=O)C)C)O)OC(C8=CC=CC=C8)=O)=O

Molecular Formula

C55H58N2O22S

Molecular Weight

1131.11

References & Citations

[1]Franco Dosio, et al. Preparation, characterization and properties in vitro and in vivo of a paclitaxel–albumin conjugate, Journal of Controlled Release, Volume 47, Issue 3, 1997, Pages 293-304, ISSN 0168-3659